IncyteCARES Patient Support Program


IncyteCARES is a personalized patient support program for people taking Jakafi® (ruxolitinib). Guided by oncology certified nurses, IncyteCARES can connect eligible patients to a variety of resources. An IncyteCARES nurse partners with you as your single point of contact to connect you with:

Graphic of a hand and Rx
Reimbursement Support

Determining patient coverage for Jakafi

Help with determining coverage for Jakafi and, if needed, providing information about appealing insurance denials or coverage restrictions

Graphic of a mailbox
Delivery Coordination

Arranging for delivery of Jakafi directly to patients or their healthcare professional.

Graphic of a hand and Rx
Financial Assistance Options*

Help lowering the cost of Jakafi for eligible patients through copay/coinsurance assistance for commercially/privately insured patients. The Patient Assistance Program (PAP) or free medication program for uninsured/underinsured patients.

Graphic of an open book
Ongoing Education and Support

IncyteCARES oncology certified nurses provide patients with continuing education and personalized support about their condition and Jakafi.

Graphic of a calendar
Temporary Access for Insurance Coverage Delays

Helping eligible patients experiencing an insurance coverage delay get Jakafi.

Graphic of a house
Connection to Support Services

Referring patients to independent third-party organizations or foundations for travel cost or copay/coinsurance assistance, emotional and educational support, counseling, and other services.

Referrals to Independent third-party organizations that may be able to assist with:
  • Arranging transportation to and from medical appointments
  • Travel cost assistance
  • Copay/coinsurance assistance
  • Emotional and educational support
INOs may also be able to provide the following services to patients and caregivers:
  • Supportive counseling for emotional, social, and practical concerns
  • Information about support groups and referrals to local services at no cost

*Terms and conditions apply.


Graphic of a Patient Copay/Coinsurance Assistance Card

If you have been prescribed Jakafi and have private or commercial prescription insurance, you may be eligible to receive Jakafi for as little as $25 per month, subject to monthly and annual limits.†‡

If you have been prescribed Jakafi, IncyteCARES may be able to assist you in meeting your copay/coinsurance.

Criteria for Copay/Coinsurance Assistance

To qualify, you must meet the following criteria:

  • Have commercial or private insurance (eg, BCBS, Aetna). Patients insured through Medicare, Medicaid, and TRICARE are not eligible. Please call 1-855-4-Jakafi for more information
  • Be a resident of the United States or Puerto Rico
  • Have a valid prescription for Jakafi for an FDA-approved use
  • Disclose the use of the card to your insurers

Amount of savings for the purchase of Jakafi will not exceed $25,000 per year. Program benefits are subject to a monthly limit. Uninsured, cash-paying patients are not eligible. Not valid for patients covered under state or federally funded healthcare programs. Valid prescription for Jakafi for an FDA-approved indication is required. Please see full criteria for eligibility at or call IncyteCARES. Patients insured through Medicare, Medicaid, and TRICARE are not eligible.


After you receive your prescription for Jakafi from your Healthcare Professional:
  • Call IncyteCARES at 1-855-4-Jakafi (1-855-452-5234)§
  • Answer a few simple questions to activate your copay/coinsurance card
  • Contact the pharmacy that is providing Jakafi and give them your card Group, Bin, and Member numbers to receive copay/coinsurance assistance for your prescription
Visit IncyteCARES to Learn More
Learn how Dan got the support he needed from IncyteCARES

Hear from Dan, a real patient taking Jakafi, as he explains how IncyteCARES helped him discover his path to possible.

§Pharmacies: Call 1-855-799-1295 to activate card.


Connect With
a Patient
Like Dan

Connect With a
Patient Like Dan

Register for the Incyte Mentor Program and connect with another patient taking Jakafi.

Email Address

Continue Registering

Expand Collapse



Jakafi is a prescription medicine used to treat adults with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.

Jakafi is used to treat adults with certain types of myelofibrosis.

Jakafi is also used to treat adults and children 12 years of age and older with acute graft-versus-host disease (GVHD) who have taken corticosteroids and they did not work well enough.

Important Safety Information

Jakafi can cause serious side effects, including:

Low blood counts: Jakafi® (ruxolitinib) may cause your platelet, red blood cell, or white blood cell counts to be lowered. If you develop bleeding, stop taking Jakafi and call your healthcare provider. Your healthcare provider will perform blood tests to check your blood counts before you start Jakafi and regularly during your treatment. Your healthcare provider may change your dose of Jakafi or stop your treatment based on the results of your blood tests. Tell your healthcare provider right away if you develop or have worsening symptoms such as unusual bleeding, bruising, tiredness, shortness of breath, or a fever.

Infection: You may be at risk for developing a serious infection during treatment with Jakafi. Tell your healthcare provider if you develop any of the following symptoms of infection: chills, nausea, vomiting, aches, weakness, fever, painful skin rash or blisters.

Skin cancers: Some people who take Jakafi have developed certain types of non-melanoma skin cancers. Tell your healthcare provider if you develop any new or changing skin lesions.

Increases in cholesterol: You may have changes in your blood cholesterol levels. Your healthcare provider will do blood tests to check your cholesterol levels during your treatment with Jakafi.

The most common side effects of Jakafi include: for certain types of MF and PV – low platelet or red blood cell counts, bruising, dizziness, and headache; and for acute GVHD – low platelet, red or white blood cell counts, infections, and fluid retention.

These are not all the possible side effects of Jakafi. Ask your pharmacist or healthcare provider for more information. Tell your healthcare provider about any side effect that bothers you or that does not go away.

Before taking Jakafi, tell your healthcare provider about: all the medications, vitamins, and herbal supplements you are taking and all your medical conditions, including if you have an infection, have or had tuberculosis (TB) or have been in close contact with someone who has TB, have or had hepatitis B, have or had liver or kidney problems, are on dialysis, have high cholesterol or triglycerides, had skin cancer, or have any other medical condition. Take Jakafi exactly as your healthcare provider tells you. Do not change your dose or stop taking Jakafi without first talking to your healthcare provider.

Women should not take Jakafi while pregnant or planning to become pregnant. Do not breastfeed during treatment with Jakafi and for 2 weeks after the final dose.

Please see the Full Prescribing Information, which includes a more complete discussion of the risks associated with Jakafi.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit, or call 1-800-FDA-1088.

You may also report side effects to Incyte Medical Information at 1-855-463-3463.